Literature DB >> 308778

Use of platelet-fibrinogen-thrombin mixture to seal experimental penetrating corneal wounds.

A R Rosenthal, P R Egbert, C Harbury, J L Hopkins, E Rubenstein.   

Abstract

A platelet-fibrinogen-thrombin mixture utilizing autologous platelets was studied for its potential to seal perforating corneal wounds. In rabbits, the mixture demonstrated sufficient adhesive properties to permit 75% of penetrating keratoplasties to remain in place without the use of sutures. All 12 grafts held initially; after 48 h three grafts extruded. In control eyes only two out of 12 (16%) of the corneal grafts remained in place. The material is simple to prepare and apply and is not toxic to the cornea. It does not cause inflammation or lid irritation. Intraocular complications observed with its use were transient anterior synechiae and retrocorneal membrane formation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 308778     DOI: 10.1007/bf00414308

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol        ISSN: 0065-6100


  4 in total

1.  Corneal scar formation.

Authors:  C Cintron; H Schneider; C Kublin
Journal:  Exp Eye Res       Date:  1973-11-11       Impact factor: 3.467

2.  Clinical applications of adhesives in corneal surgery.

Authors:  S A Boruchoff; M Refojo; H H Slansky; R G Webster; M I Freeman; C H Dohlman
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1969 May-Jun

3.  The use of adhesive for the closure of corneal perforations. Report of two cases.

Authors:  R G Webster; H H Slansky; M F Refojo; S A Boruchoff; C H Dohlman
Journal:  Arch Ophthalmol       Date:  1968-12

4.  Use of a platelet-fibrinogen-thrombin mixture as a corneal adhesive: experiments with sutureless lamellar keratoplasty in the rabbit.

Authors:  A R Rosenthal; C Harbury; P R Egbert; E Rubenstein
Journal:  Invest Ophthalmol       Date:  1975-11
  4 in total
  6 in total

1.  Merchants shall be expelled from the Temple: the PRGF(®) (Plasma-Preparation Rich in Growth Factors)-Endoret(®) case.

Authors:  David M Dohan Ehrenfest; Chang-Qing Zhang; Nelson R Pinto; Tomasz Bielecki
Journal:  Muscles Ligaments Tendons J       Date:  2015-02-05

Review 2.  Platelet Derived Biomaterials for Therapeutic Use: Review of Technical Aspects.

Authors:  Satyam Arora; Naveen Agnihotri
Journal:  Indian J Hematol Blood Transfus       Date:  2016-03-29       Impact factor: 0.900

3.  Role of Leukocyte-Platelet-Rich Fibrin in Endoscopic Endonasal Skull Base Surgery Defect Reconstruction.

Authors:  Liuba Soldatova; Raewyn G Campbell; Ahmad H Elkhatib; Thomas W Schmidt; Nelson R Pinto; Jaime M Pinto; Daniel M Prevedello; Leo F Ditzel Filho; Bradley A Otto; Ricardo L Carrau
Journal:  J Neurol Surg B Skull Base       Date:  2016-06-28

Review 4.  Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives.

Authors:  David M Dohan Ehrenfest; Isabel Andia; Matthias A Zumstein; Chang-Qing Zhang; Nelson R Pinto; Tomasz Bielecki
Journal:  Muscles Ligaments Tendons J       Date:  2014-05-08

Review 5.  Evolution, current status and advances in application of platelet concentrate in periodontics and implantology.

Authors:  Amit Arvind Agrawal
Journal:  World J Clin Cases       Date:  2017-05-16       Impact factor: 1.337

Review 6.  Non-Transfusional Hemocomponents: From Biology to the Clinic-A Literature Review.

Authors:  Roberta Gasparro; Erda Qorri; Alessandra Valletta; Michele Masucci; Pasquale Sammartino; Alessandra Amato; Gaetano Marenzi
Journal:  Bioengineering (Basel)       Date:  2018-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.